Literature DB >> 14608116

The role of dietary supplements during cancer therapy.

Helen A Norman1, Ritva R Butrum, Elaine Feldman, David Heber, Daniel Nixon, Mary Frances Picciano, Richard Rivlin, Artemis Simopoulos, Michael J Wargovich, Elizabeth K Weisburger, Steven H Zeisel.   

Abstract

This guide was compiled after recommendations by the American Institute for Cancer Research (AICR) Cancer Resource Advisory Council. It encompasses the AICR position on current issues in nutrition for cancer survivors during treatment and is intended to provide advice about dietary supplements for cancer survivors who are still being treated. Current scientific findings about the safety and effectiveness of some commonly used dietary antioxidants and nonantioxidant supplements during chemotherapy are presented and assessed. Use of dietary supplements during cancer treatment remains controversial. Patients are cautioned that vitamin and mineral supplements as therapies are not substitutes for established medicine. The current recommendation for cancer patients is to only take moderate doses of supplements because evidence from human clinical studies that confirm their safety and benefits is limited. A daily multivitamin containing supplements at the levels of the Dietary Reference Intakes can be used safely as part of a program of healthy nutrition. In addition, the AICR Cancer Resource Advisory Council concluded that further scientific research is needed to provide a set of firm guidelines for the use of vitamin and mineral supplements by cancer patients during treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14608116     DOI: 10.1093/jn/133.11.3794S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  23 in total

1.  Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).

Authors:  Christine B Ambrosone; Gary R Zirpoli; Alan D Hutson; William E McCann; Susan E McCann; William E Barlow; Kara M Kelly; Rikki Cannioto; Lara E Sucheston-Campbell; Dawn L Hershman; Joseph M Unger; Halle C F Moore; James A Stewart; Claudine Isaacs; Timothy J Hobday; Muhammad Salim; Gabriel N Hortobagyi; Julie R Gralow; George T Budd; Kathy S Albain
Journal:  J Clin Oncol       Date:  2019-12-19       Impact factor: 44.544

2.  Knowledge, attitude and practices related to dietary supplements and micronutrients in health sciences students.

Authors:  Ajitha Sharma; Shalini Adiga; Ashok M
Journal:  J Clin Diagn Res       Date:  2014-08-20

3.  Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).

Authors:  Dawn L Hershman; Joseph M Unger; Katherine D Crew; Cathee Till; Heather Greenlee; Lori M Minasian; Carol M Moinpour; Danika L Lew; Louis Fehrenbacher; James L Wade; Siu-Fun Wong; Michael J Fisch; N Lynn Henry; Kathy S Albain
Journal:  J Natl Cancer Inst       Date:  2018-06-01       Impact factor: 13.506

4.  Treatment- and disease-related complications of prostate cancer.

Authors:  Anne R Simoneau
Journal:  Rev Urol       Date:  2006

Review 5.  Nutritional and Exercise Interventions in Cancer-Related Cachexia: An Extensive Narrative Review.

Authors:  Vicente Javier Clemente-Suárez; Laura Redondo-Flórez; Alejandro Rubio-Zarapuz; Ismael Martínez-Guardado; Eduardo Navarro-Jiménez; José Francisco Tornero-Aguilera
Journal:  Int J Environ Res Public Health       Date:  2022-04-11       Impact factor: 4.614

6.  Dietary supplement use in adult cancer survivors.

Authors:  Paige E Miller; Joseph J Vasey; Pamela F Short; Terryl J Hartman
Journal:  Oncol Nurs Forum       Date:  2009-01       Impact factor: 2.172

7.  Dietary and serum lycopene levels in prostate cancer patients undergoing intensity-modulated radiation therapy.

Authors:  Mridul Datta; Martha L Taylor; Bart Frizzell
Journal:  J Med Food       Date:  2013-11-04       Impact factor: 2.786

8.  Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest.

Authors:  Julian J Raffoul; Yu Wang; Omer Kucuk; Jeffrey D Forman; Fazlul H Sarkar; Gilda G Hillman
Journal:  BMC Cancer       Date:  2006-04-26       Impact factor: 4.430

9.  Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

Authors:  Dawn L Hershman; Joseph M Unger; Katherine D Crew; Lori M Minasian; Danielle Awad; Carol M Moinpour; Lisa Hansen; Danika L Lew; Heather Greenlee; Louis Fehrenbacher; James L Wade; Siu-Fun Wong; Gabriel N Hortobagyi; Frank L Meyskens; Kathy S Albain
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

10.  Supplement use during an intergroup clinical trial for breast cancer (S0221).

Authors:  Gary R Zirpoli; Patrick M Brennan; Chi-Chen Hong; Susan E McCann; Gregory Ciupak; Warren Davis; Joseph M Unger; G Thomas Budd; Dawn L Hershman; Halle C F Moore; James Stewart; Claudine Isaacs; Timothy Hobday; Muhammad Salim; Gabriel N Hortobagyi; Julie R Gralow; Kathy S Albain; Christine B Ambrosone
Journal:  Breast Cancer Res Treat       Date:  2013-01-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.